NDC 85006-1755 – Alymsys
Bevacizumab-maly 400 mg/16mL · Injection, Solution · Intravenous
Product NDC85006-1755
Product details
- Brand name
- Alymsys
- Generic name
- Bevacizumab-maly
- Labeler
- Valorum Biologics, LLC
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- BLA · BLA761231
- Marketed since
- March 30, 2026
- Listing expires
- December 31, 2027
- Pharmacologic class
- Vascular Endothelial Growth Factor Inhibitor
Active ingredients
- Bevacizumab-maly 400 mg/16mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 85006-1755-1 | 1 VIAL in 1 CARTON (85006-1755-1) / 16 mL in 1 VIAL | Mar 30, 2026 |
Other Alymsys products
- 70121-1754 Bevacizumab 100 mg/4mL · Injection, Solution · Amneal Pharmaceuticals LLC
- 70121-1755 Bevacizumab 400 mg/16mL · Injection, Solution · Amneal Pharmaceuticals LLC
- 85006-1754 Bevacizumab-maly 100 mg/4mL · Injection, Solution · Valorum Biologics, LLC